Last update 24 Apr 2026

Icosapent ethyl/Rosuvastatin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Ethyl eicosapentaenoic acid/rosuvastatin, Vascepa/rosuvastatin, AMR-102
Target
HMGCR
Action
inhibitors
Mechanism
HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
Lipid Metabolism Disorders
Inactive Indication
HypercholesterolemiaHyperlipidemias
Originator Organization
Amarin Pharma, Inc.Amarin Pharma, Inc.
Active Organization
Althera Pharmaceuticals
Inactive Organization
Amarin Corp. PlcAmarin Corp. PlcAmarin Pharma, Inc.Amarin Pharma, Inc.
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC22H28FN3O6S
InChIKeyBPRHUIZQVSMCRT-VEUZHWNKSA-N
CAS Registry287714-41-4
View All Structures (2)

Related

100 Clinical Results associated with Icosapent ethyl/Rosuvastatin
Login to view more data
100 Translational Medicine associated with Icosapent ethyl/Rosuvastatin
Login to view more data
100 Patents (Medical) associated with Icosapent ethyl/Rosuvastatin
Login to view more data
100 Deals associated with Icosapent ethyl/Rosuvastatin
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HypercholesterolemiaPhase 1-
Amarin Pharma, Inc.Amarin Pharma, Inc.
-
HyperlipidemiasPhase 1
United States
Amarin Corp. PlcAmarin Corp. Plc
-
Lipid Metabolism DisordersPreclinical
United States
Althera Pharmaceuticals
01 Sep 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free